Illumina (ILMN) Competitors $101.80 +2.51 (+2.53%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$102.58 +0.78 (+0.77%) As of 08/22/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Its Competitors Agilent Technologies Mettler-Toledo International Waters Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Illumina (NASDAQ:ILMN) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations. Is ILMN or A more profitable? Illumina has a net margin of 29.36% compared to Agilent Technologies' net margin of 17.59%. Illumina's return on equity of 28.93% beat Agilent Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Illumina29.36% 28.93% 10.74% Agilent Technologies 17.59%25.92%13.24% Do analysts rate ILMN or A? Illumina presently has a consensus price target of $124.58, suggesting a potential upside of 22.38%. Agilent Technologies has a consensus price target of $139.77, suggesting a potential upside of 15.04%. Given Illumina's higher possible upside, equities research analysts plainly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Illumina 2 Sell rating(s) 11 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.25Agilent Technologies 0 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.54 Does the media prefer ILMN or A? In the previous week, Agilent Technologies had 14 more articles in the media than Illumina. MarketBeat recorded 33 mentions for Agilent Technologies and 19 mentions for Illumina. Illumina's average media sentiment score of 1.66 beat Agilent Technologies' score of 1.35 indicating that Illumina is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 19 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Agilent Technologies 26 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of ILMN or A? 89.4% of Illumina shares are held by institutional investors. 2.6% of Illumina shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has higher earnings & valuation, ILMN or A? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIllumina$4.37B3.58-$1.22B$7.9012.89Agilent Technologies$6.51B5.30$1.29B$4.0530.00 Which has more risk & volatility, ILMN or A? Illumina has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. SummaryIllumina beats Agilent Technologies on 8 of the 15 factors compared between the two stocks. Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.65B$3.11B$5.81B$9.76BDividend YieldN/A2.23%4.39%4.06%P/E Ratio12.8921.0031.3626.05Price / Sales3.58209.44387.8788.42Price / Cash21.7044.5038.0259.36Price / Book6.938.129.536.60Net Income-$1.22B-$54.72M$3.26B$265.65M7 Day Performance1.69%2.62%2.14%2.00%1 Month Performance-5.43%3.25%3.22%0.46%1 Year Performance-22.52%10.82%30.18%18.88% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.6529 of 5 stars$101.80+2.5%$124.58+22.4%-22.5%$15.65B$4.37B12.899,030Positive NewsAAgilent Technologies4.8806 of 5 stars$118.44-0.6%$139.77+18.0%-13.7%$33.65B$6.51B29.2417,900News CoveragePositive NewsUpcoming EarningsMTDMettler-Toledo International4.0007 of 5 stars$1,315.45+0.2%$1,288.89-2.0%-8.0%$27.10B$3.87B33.3117,300News CoveragePositive NewsAnalyst ForecastInsider TradeWATWaters4.8261 of 5 stars$289.15-0.8%$378.73+31.0%-11.8%$17.21B$3.05B26.077,600Trending NewsTECHBio-Techne4.8462 of 5 stars$53.29-0.6%$69.42+30.3%-21.0%$8.35B$1.22B115.853,100News CoveragePositive NewsDividend AnnouncementAnalyst UpgradeCRLCharles River Laboratories International4.0103 of 5 stars$157.27+0.4%$175.69+11.7%-21.3%$7.74B$4.05B-118.2520,100News CoveragePositive NewsInsider TradeBIOBio-Rad Laboratories4.5657 of 5 stars$284.39-0.4%$333.50+17.3%-3.8%$7.70B$2.57B24.247,700Positive NewsAnalyst DowngradeBRKRBruker4.9679 of 5 stars$34.24+2.1%$51.30+49.8%-44.6%$5.19B$3.37B65.8511,396PACBPacific Biosciences of California2.2384 of 5 stars$1.33+1.5%$1.90+42.9%-11.5%$399.49M$154.01M-0.58730Positive NewsHBIOHarvard Bioscience3.8354 of 5 stars$0.50-4.6%$3.00+494.4%-83.6%$22.48M$88.75M-0.39490Gap UpTMOThermo Fisher Scientific4.9172 of 5 stars$488.15-0.2%$593.00+21.5%-17.5%$184.33B$42.88B28.23125,000Trending NewsInsider TradeAnalyst Revision Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access